Plain-English translation of NCT06735248 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Sclerosis research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing an experimental medication called , which is a new type of treatment designed to help prevent relapses in people with multiple sclerosis. The study will compare this medication at two different dose levels against a placebo (a dummy injection with no active drug) to see which dose works best and how safe the treatment is. About 180 people will participate.
Multiple sclerosis relapses can be unpredictable and damaging to the nervous system, so doctors are looking for new ways to prevent them. This medication represents a new approach that researchers hope could help people with early-stage MS stay healthier longer.
You likely qualify if…
You likely don't qualify if…
If you join, you will receive three injections over six months (at the start, after two months, and after six months). You'll be randomly assigned to receive either the low-dose medication, the high-dose medication, or a placebo. Throughout the study, you'll have medical visits to check your safety, discuss any side effects, and have blood tests. The study will track how well the medication works at preventing relapses and what side effects, if any, people experience.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
United States